P. Ferrari

发表

Inhibitors of Civ1 kinase belonging to 6-aminoaromatic-2-cyclohexyldiamino purine series as potent anti-fungal compounds.

N. Jullian, N. Bouquin, Florence Bordon-Pallier, 2004, Biochimica et biophysica acta.

Large-scale preparation, purification, and crystallization of UDP-N-acetylmuramoyl-L-alanine: D-glutamate ligase from Escherichia coli.

E. Fanchon, O. Dideberg, Y. Pétillot, 1998, Protein Expression and Purification.

SAR650984, A Novel Humanized CD38-Targeting Antibody, Demonstrates Potent Antitumor Activity in Models of Multiple Myeloma and Other CD38+ Hematologic Malignancies

J. Deckert, T. Chittenden, A. Plesa, 2014, Clinical Cancer Research.

The Mtr2-Mex67 NTF2-like Domain Complex

D. Platel, P. Ferrari, Y. Bourne, 2003, Journal of Biological Chemistry.

Preclinical Activity of SAR408701: A Novel Anti-CEACAM5–maytansinoid Antibody–drug Conjugate for the Treatment of CEACAM5-positive Epithelial Tumors

C. García-echeverría, C. Nicolazzi, J. Mayaux, 2020, Clinical Cancer Research.

Comprehensive study on structure-activity relationships of rifamycins: discussion of molecular and crystal structure and spectroscopic and thermochemical properties of rifamycin O.

A. Bacchi, P. Ferrari, G. Pelizzi, 1998, Journal of medicinal chemistry.

A single T cell epitope drives the neutralizing anti-drug antibody response to natalizumab in multiple sclerosis patients

R. Geiger, D. Jarrossay, F. Sallusto, 2019, Nature Medicine.

Reaction mechanism of phosphoglucosamine mutase from Escherichia coli.

J. Heijenoort, D. Mengin-Lecreulx, P. Ferrari, 1999, European journal of biochemistry.

Cancer Therapy : Preclinical SAR 650984 , A Novel Humanized CD 38-Targeting Antibody , Demonstrates Potent AntitumorActivity inModels ofMultiple Myeloma and Other CD 38 þ Hematologic Malignancies

C. Dumontet, P. Ferrari, V. Goldmacher, 2014 .

Cancer Therapy: Preclinical SAR650984, A Novel Humanized CD38-Targeting Antibody, Demonstrates Potent AntitumorActivity inModels ofMultiple Myeloma and Other CD38þ Hematologic Malignancies

C. Dumontet, P. Ferrari, V. Goldmacher, 2014 .

Fluorescence Detection-Based Functional Assay for High-Throughput Screening for MraY

D. Mengin-Lecreulx, P. Ferrari, J. Biton, 2004, Antimicrobial Agents and Chemotherapy.

Tricyclic series of heat shock protein 90 (Hsp90) inhibitors part I: discovery of tricyclic imidazo[4,5-c]pyridines as potent inhibitors of the Hsp90 molecular chaperone.

Paul Ferrari, Patrick Mailliet, Hervé Minoux, 2011, Journal of medicinal chemistry.

Crystal structures of two human pyrophosphorylase isoforms in complexes with UDPGlc(Gal)NAc: role of the alternatively spliced insert in the enzyme oligomeric assembly and active site architecture

P. Ferrari, Y. Bourne, Y Bourne, 2001, The EMBO journal.

UMP kinase from Streptococcus pneumoniae: evidence for co-operative ATP binding and allosteric regulation.

P. Ferrari, M. Lowinski, F. Fassy, 2004, The Biochemical journal.

Structures of a pan‐specific antagonist antibody complexed to different isoforms of TGFβ reveal structural plasticity of antibody–antigen interactions

M. Mathieu, Huawei Qiu, R. Wei, 2014, Protein science : a publication of the Protein Society.

Trispecific antibodies enhance the therapeutic efficacy of tumor-directed T cells through T cell receptor co-stimulation

G. Nabel, M. Chiron, Huawei Qiu, 2019, Nature Cancer.

Systemic immune‐checkpoint blockade with anti‐PD1 antibodies does not alter cerebral amyloid‐β burden in several amyloid transgenic mouse models

Nicolas Moindrot, G. Nabel, Yaming Wang, 2018, Glia.

CODV-Ig, a universal bispecific tetravalent and multifunctional immunoglobulin format for medical applications

Alain Dupuy, Paul Ferrari, Christian Lange, 2016, mAbs.

Large-Scale Preparation, Purification, and Crystallization of UDP-N-Acetylmuramoyl-l-Alanine:d-Glutamate Ligase fromEscherichia coli☆

Paul Ferrari, Eric Fanchon, Jean van Heijenoort, 1998 .

A Robust Multiplex Mass Spectrometric Assay for Screening Small-Molecule Inhibitors of CD73 with Diverse Inhibition Modalities

R. Gregory, S. Licht, P. Ferrari, 2018, SLAS discovery : advancing life sciences R & D.

Structures of a pan‐specific antagonist antibody complexed to different isoforms of TGFβ reveal structural plasticity of antibody–antigen interactions

M. Mathieu, Huawei Qiu, R. Wei, 2014, Protein science : a publication of the Protein Society.

SAR650984, A Novel Humanized CD38-Targeting Antibody, Demonstrates Potent Antitumor Activity in Models of Multiple Myeloma and Other CD38+ Hematologic Malignancies

T. Chittenden, A. Plesa, M. Chiron, 2014, Clinical Cancer Research.